课题基金 / 基金详情

Transcriptional regulation of CCR10 expression in plasma cells

Transcriptional regulation of CCR10 expression in plasma cells
浆细胞中 CCR10 表达的转录调控
批准号:
17590443
负责人:
YOSHIE Osamu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

YOSHIE Osamu的其他基金

相似基金

相关文献

中文摘要
翻译
CCR10已被报道在几乎所有分泌IgA的浆细胞中都有表达,而其配体CCL28在各种粘膜组织中广泛表达。因此,CCR10-CCL28系统很可能在常见的粘膜免疫系统中贡献了广泛的分泌IgA的浆细胞。在此,我们研究了CCR10在B细胞终末分化中的表达机制。据报道,经IL-21处理后活化的人CD19^B细胞可有效地分化为IGD^-CD38^浆细胞。即使IGD^-CD38^细胞不自发表达CCR10,但如果在1,25-二羟基维生素D3(1,25-(OH)_2D_3)的存在下诱导分化,相当一部分细胞会表达CCR10,1,25-(OH)_2D_3作为佐剂可促进常见的粘膜免疫反应。然而,我们观察到1,25-(OH)_2D_3对IgA细胞几乎没有增加。为了确定1,25-(OH)_2D_3诱导终末分化B细胞CCR10表达的转录机制,我们接下来对CCR10启动子进行了一系列分析。记者对一系列5‘端缺失的启动子片段和定点突变的启动子片段的分析表明,Ets-1近端的一个位点和上游的维生素D3反应元件(VDRE)对CCR10的表达至关重要。利用表达CCR10的骨髓瘤细胞系的核提取液进行NoShift转录因子结合分析,证实了Ets-1和1,25-(OH)_2D_3激活的维生素D3受体(VDR)与相应元件的特异性结合。总的来说,1,25-(OH)2D3在体外能有效地诱导IL-21诱导的人浆细胞CCR10的表达。此外,CCR10启动子被1,25-(OH)_2D_3激活的VDR和Ets-1协同激活。
英文摘要
CCR10 has been reported to be expressed by almost all IgA-secreting plasma cells, while its ligand CCL28 is widely expressed in various mucosal tissues. Thus, the CCR10-CCL28 system is likely to contribute a wide distribution of IgA-secreting plasma cells in the common mucosal immune system. Here we examined the mechanism of CCR10 expression in terminally differentiating B cells. As reported previously, activated human CD19^+ B cells treated with IL-21 efficiently differentiated into IgD^-CD38^+ plasma cells. Even though IgD^-CD38^+ cells did not spontaneously expressed CCR10, a substantial fraction turned to express CCR10 if the differentiation was induced in the presence of 1,25-dihydroxyvitamin D3 (1,25-(OH)_2D_3), which is known to promote common mucosal immune responses if used as an adjuvant. However, we observed little increases in IgA^+ cells by 1,25-(OH)_2D_3. To determine the transcriptional mechanism regulating 1,25-(OH)_2D_3-inducible expression of CCR10 in terminally differentiating B cells, we next carried out a series of analysis on the CCR10 promoter. The reporter assays involving a series of 5'-deleted promoter fragments and promoter fragments with site-directed mutations revealed that a proximal Ets-1 site and an upstream vitamin D3 response element (VDRE) were critical for CCR10 expression. The NoShift transcription factor binding assays using nuclear extracts from CCR10-expressing myeloma cell lines confirmed specific binding of Ets-1 and 1,25-(OH)_2D_3-activated vitamin D3 receptor (VDR) to the respective elements. Collectively, 1,25-(OH)2D3 efficiently induces CCR10 expression in IL-21-induced human plasma cells in vitro. Furthermore, the CCR10 promoter is cooperatively activated by 1,25-(OH)_2D_3-activated VDR and Ets-1.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
免疫研究最前線2007「形質細胞の分化制御と移動制御」
免疫学研究前沿2007“浆细胞分化和迁移的控制”
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Umemoto E, Tanaka T, Kanda H, Jin S, Tohya K, Otani K, Matsutani T, Matsumoto M, Ebisuno Y, Jang MH, Fukuda M, Hirata T, Miyasaka M, 義江 修(分担執筆)]
通讯作者: 義江 修(分担執筆)
Learning support mechanism based on analysis of consensus building among users
  • 批准号:
    15K00495
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.58万
  • 财政年份:
    2015
  • 负责人:
    YOSHIE Osamu
  • 依托单位:
Role of CCL28 for mucosal immunity
  • 批准号:
    26460582
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.24万
  • 财政年份:
    2014
  • 负责人:
    YOSHIE Osamu
  • 依托单位:
Transcriptional regulation of CCR7 expression in mature T-cell malignancies
  • 批准号:
    23501273
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2011
  • 负责人:
    YOSHIE Osamu
  • 依托单位:
Study on the pathophysiological role of the Th2-type chemokine receptor CCR4
  • 批准号:
    19390277
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.56万
  • 财政年份:
    2007
  • 负责人:
    YOSHIE Osamu
  • 依托单位:
国内基金
海外基金
FOXK2转录调控CCR10促进骨髓瘤细胞招募和激活肿瘤相关成纤维细胞的的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    张幸鼎
  • 依托单位:
IL-22调控角质形成细胞CCL27/CCL28及Th22细胞CCR10在银屑病发病中的作用研究
  • 批准号:
    81773319
  • 项目类别:
    面上项目
  • 资助金额:
    50.0万元
  • 批准年份:
    2017
  • 负责人:
    罗素菊
  • 依托单位:
ILC2细胞经CCL27/CCR10信号对急性放射性损伤的调控作用研究
  • 批准号:
    81673099
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2016
  • 负责人:
    赵烨
  • 依托单位:
趋化因子CCL28及其受体CCR10在行IVF-ET后输卵管妊娠母-胎界面上的生物学作用和对话机制
  • 批准号:
    81200408
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    张佳荣
  • 依托单位: